September 28 marks a huge day in diabetes technology in the US! In unexpected and truly outstanding news for people with diabetes, the FDA approved TWO long-awaited diabetes products: Abbott’s FreeStyle Libre Pro AND Medtronic’s MiniMed 670G Hybrid Closed Loop system. Medtronic will launch the 670G in the US in Spring 2017, bringing the first system to automate basal insulin delivery to market. FreeStyle Libre Pro – a “blinded” sensor applied in a healthcare provider’s office and worn for two weeks – will be made available in the coming weeks. The “consumer” (real-time) version of FreeStyle Libre is currently under FDA review, meaning it could be approved in early 2017.